• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类维生素P化合物对高胆固醇血症中溶酶体脆性的作用:抗坏血酸及其代谢产物的影响

Action of vitamin P like compounds on lysosomal fragility in hypercholesterolemia: implication of ascorbic acid and its metabolites.

作者信息

Rathi A B, Nath N, Chari S N

出版信息

Acta Vitaminol Enzymol. 1984;6(2):97-102.

PMID:6496258
Abstract

Possible mechanisms responsible for hepatic lysosomal fragility in hypercholesterolemic rats have been investigated. It was found that certain factor(s) present in the intracellular environment of liver were required for the release of lysosomal enzymes. Elevated hepatic dehydroascorbic acid content in hypercholesterolemic rats is thought to render the lysosomes fragile in this pathological state, since this compound was found to labilise the lysosomes in vitro. Quercetin and hesperidin were found to be responsible for lysosomal stability, probably by reducing the content of dehydroascorbic acid to a normal level in the hypercholesterolemic condition.

摘要

对高胆固醇血症大鼠肝脏溶酶体脆弱性的可能机制进行了研究。发现肝脏细胞内环境中存在的某些因素是溶酶体酶释放所必需的。高胆固醇血症大鼠肝脏脱氢抗坏血酸含量升高被认为使溶酶体在这种病理状态下变得脆弱,因为在体外发现这种化合物会使溶酶体不稳定。发现槲皮素和橙皮苷对溶酶体稳定性起作用,可能是通过在高胆固醇血症状态下将脱氢抗坏血酸含量降低到正常水平。

相似文献

1
Action of vitamin P like compounds on lysosomal fragility in hypercholesterolemia: implication of ascorbic acid and its metabolites.类维生素P化合物对高胆固醇血症中溶酶体脆性的作用:抗坏血酸及其代谢产物的影响
Acta Vitaminol Enzymol. 1984;6(2):97-102.
2
Action of vitamin P like compounds on lysosomal status in hypercholesterolemic rats.维生素P样化合物对高胆固醇血症大鼠溶酶体状态的作用
Acta Vitaminol Enzymol. 1983;5(4):255-61.
3
In vitro effect of certain compounds on the lysosomal release of polymorphonuclear leukocytes.某些化合物对多形核白细胞溶酶体释放的体外作用。
Indian J Physiol Pharmacol. 1983 Jul-Sep;27(3):227-33.
4
Cholesterol lowering action of vitamin P-like compounds in rats.类维生素P化合物对大鼠的降胆固醇作用。
Indian J Exp Biol. 1981 Aug;19(8):787-9.
5
Factor(s) responsible for hepatic lysosomal release in normal and hypercholesterolemic states.正常和高胆固醇血症状态下导致肝脏溶酶体释放的因素。
Indian J Biochem Biophys. 1984 Dec;21(6):402-5.
6
Action of bioflavonoids on lipid peroxidation & glutathione redox system in hypercholesterolemic rats.
Indian J Med Res. 1984 Apr;79:508-13.
7
Intracellular accumulation of ascorbic acid is inhibited by flavonoids via blocking of dehydroascorbic acid and ascorbic acid uptakes in HL-60, U937 and Jurkat cells.在HL-60、U937和Jurkat细胞中,类黄酮通过阻断脱氢抗坏血酸和抗坏血酸的摄取来抑制抗坏血酸的细胞内积累。
J Nutr. 2000 May;130(5):1297-302. doi: 10.1093/jn/130.5.1297.
8
Some studies on ascorbic acid metabolism in hydrazine-treated rats.关于肼处理大鼠体内抗坏血酸代谢的一些研究。
Int J Vitam Nutr Res. 1978;48(2):152-8.
9
Effect of flavonoids on vitamin C activity of D-isoascorbic acid.类黄酮对D-异抗坏血酸维生素C活性的影响。
Physiol Bohemoslov. 1979;28(6):519-24.
10
Influence of bioflavonoids on lysosomal acid hydrolases and lysosomal stability.生物类黄酮对溶酶体酸性水解酶及溶酶体稳定性的影响。
Ital J Biochem. 1981 Jan-Feb;30(1):46-53.